Prevention Pilot Program

The purpose of the SMD Strategic Plan Pilot Award Program is to promote the research goals of scientific programs of excellence in biomedical research with the potential to enhance the national and international reputation of the School of Medicine and Dentistry and the University. Funded pilot projects are envisioned as innovative research directions with the potential to give new life to the overall scientific portfolio of the UR and keep the institution abreast of, and even ahead of today’s fast-paced and competitive scientific landscape.  Multidisciplinary and multi-investigator proposals are strongly encouraged.

The Prevention Pilot Program is intended to support the development of Prevention Research into a program of excellence for the institution.  It is designed to fund innovative pilot projects focused on communicable or chronic disease prevention, including both physical and mental health problems. The focus of the award is on primary (to prevent disease) and secondary prevention (to decrease the impact of established disease) and, although it is anticipated that awards are likely to be for T3 and T4 projects, proposals across the spectrum of translational research are invited.  Emphasis is on topics that reflect the needs of the nation to improve health (identified in Healthy People 2020 (www.healthypeople.gov), other CDC identified areas of public health importance e.g., Winnable Battles (www.cdc.gov/winnablebattles), Health Action priorities (www.healthaction.org) and areas of strength for the University of Rochester.  Proposals should be likely to result in the development of areas of excellence and with a high probability of attracting extramural funding.  Studies that advance measurement methods and/or implementation science are also welcomed, as well as analysis of secondary data if relevant to the areas of interest noted above.  This funding is not intended to support proposals that could be funded through other mechanisms, basic science, or standard randomized clinical trials.  Innovative study designs are welcome.

Abstracts are due by 5:00 PM on April 7, 2014.
Click here for the RFP. Click here for the funding attestation template.

 

 

NIH Funding Acknowledgement ** Important ** All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH FUNDING ACKNOWLEDGEMENT and must comply with the NIH Public Access Policy.